In PME’s last issue for 2017 we wrap up a busy year for the European pharma industry.
The last 12 months have seen more questions than answers arise from Brexit, though we do at least now know where the EMA will reside in March 2019.
In addition to Amsterdam’s winning bid, December’s PME looks at the strategic imperative that is marketing effectiveness and we hear from Ipsen’s Alexandre Lebeaut on his company’s plans in oncology.
We also celebrate past excellence with a detailed look at the 2017 PMEA awards, where AbbVie, Sanofi and Bayer were among those picking up one of the coveted trophies.
Looking ahead we’ve covered the implications of Amazon’s anticipated move into the pharma market and there’s an assessment of why patient involvement in health technology assessment is proving so crucial.
Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.
PME is also available to download as an app for iPhone and iPad
